AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06488469 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychological Interventions for children and adolescents
Description: Psychological Interventions for children and adolescents:~* Behavioral modifications using Functional Analysis and Parent Management Techniques~* Illness Management behavior - Motivational Interviewing, Cognitive Therapy to identify thinking errors posing challenges to self-management, Behavioral Modification to enhance self-management of illness, Solution focused therapy to manage identified barriers in illness -management~* Managing emotional problems- Cognitive Behavioral Therapy techniques~Psychological Interventions for Parents/ Caregivers:~* Parent management techniques- Identification of problem behaviors/deficit~* Education on Dysfunctional attitude and their effects Psycho-education for Children could be delivered best in Combined with Health Education and Nutritional education leading to dietary modifications.~* Individualized Treatment targets and Resetting targets
Study NCT06488469 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychological Interventions for children and adolescents
Description: Psychological Interventions for children and adolescents:~* Behavioral modifications using Functional Analysis and Parent Management Techniques~* Illness Management behavior - Motivational Interviewing, Cognitive Therapy to identify thinking errors posing challenges to self-management, Behavioral Modification to enhance self-management of illness, Solution focused therapy to manage identified barriers in illness -management~* Managing emotional problems- Cognitive Behavioral Therapy techniques~Psychological Interventions for Parents/ Caregivers:~* Parent management techniques- Identification of problem behaviors/deficit~* Education on Dysfunctional attitude and their effects Psycho-education for Children could be delivered best in Combined with Health Education and Nutritional education leading to dietary modifications.~* Individualized Treatment targets and Resetting targets
Study NCT06449209 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BNT327 Dose Level 1 (DL1)
Description: Intravenous (IV) infusion
Study NCT06449209 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BNT327 Dose Level 2 (DL2)
Description: IV infusion
Study NCT06449209 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: IV infusion
Study NCT06449209 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: IV infusion
Study NCT06449209 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: IV infusion
Study NCT06449209 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topotecan
Description: IV infusion or oral capsules
Study NCT06515574 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: developmental care
Description: Individualized Developmental Care that includes the light, noise, sleep, etc.
Study NCT05573945 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Education and Active Listening
Description: Bedside intervention directly with infant with trained healthcare providers and parents. Includes family education meetings completed with individual infant parent/s and trained operator. In addition, weekly meetings of parent/s with a psychologist in a private location for an active listening counselling session.
Study NCT05573945 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Family Education
Description: Bedside intervention directly with infant with trained healthcare providers and parents. Includes family education meetings completed with individual infant parent/s and trained operator.
Study NCT04424745 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Simultaneous Attention Bias Modification Training and Transcranial Direct Current Stimulation (tDCS)
Description: Participants will receive 10 sessions of computerised attention bias modification training with either real or sham tDCS. Participants will self-administer tDCS at home, with research supervision, and complete attention bias modification training on a laptop or desktop computer while receiving stimulation. Sessions will be completed week daily for 2-3 weeks.
Study NCT04424745 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Simultaneous Attention Bias Modification Training and Transcranial Direct Current Stimulation (tDCS)
Description: Participants will receive 10 sessions of computerised attention bias modification training with either real or sham tDCS. Participants will self-administer tDCS at home, with research supervision, and complete attention bias modification training on a laptop or desktop computer while receiving stimulation. Sessions will be completed week daily for 2-3 weeks.
Study NCT05100303 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone Hydrochloride liposome injection
Description: Mitoxantrone hydrochloride liposome will be administered by intravenous (IV) injections.
Study NCT05100303 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine (LoDAC)
Description: Low-dose or high-dose cytarabine (LoDAC) will be administered by intravenous (IV) injections.
Study NCT04648657 — intervention group
Intervention type: DEVICE
Intervention: Lung Ultrasound
Description: Echography of Lungs based on artifacts study
Study NCT04648657 — intervention group
Intervention type: DEVICE
Intervention: Electric impedance tomography
Description: Low alternating electrical currents (usually \<5 milliampere at 50-80 kHz) applied through different pair of electrodes on thorax
Study NCT06314360 — intervention group
Intervention type: OTHER
Intervention: No intervention.
Description: There is no intervention in this study.
Study NCT05369143 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chiropractic care
Description: The mechanical properties of chiropractic adjustment have been investigated; and although the actual force applied to the patient's spine depends on the chiropractor, the patient, and the spinal location of the subluxation, the general shape of the force-time history of spinal adjustments is very consistent68 and the duration of the thrust is always less than 200 milliseconds.
Study NCT05369143 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control Group
Description: The participants head and/or spine will be moved in ways that include passive and active movements, similar to what is done when assessing the spine by a chiropractor. The sham intervention will also include the participants moving into adjustment setup positions similar to how the chiropractor would typically set up a patient with no joint pre-loading or adjustive thrust
Study NCT05743777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: 400 mg IV q6 weekly for a maximum of 18 cycles
Study NCT05743777 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pembrolizumab
Description: 400 mg IV q6 weekly for a maximum of 18 cycles
Study NCT05743777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MET-4
Description: Cycle 1: 5 g (10 capsules) on days -7 and -6 and 1.5 g (3 capsules) on day -5 and every day thereafter Cycle 2 onwards: 1.5 g (3 capsules) daily
Study NCT05743777 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Cycle 1: 5 g (10 capsules) on days -7 and -6 and 1.5 g (3 capsules) on day -5 and every day thereafter Cycle 2 onwards: 1.5 g (3 capsules) daily
Study NCT05926141 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACE intervention
Description: Participants attend the ACE Program for 12 weeks after school. On one assigned day of the week, participants attend ACE in person after school. The session begins with mindfulness exercises (15 minutes), professional development session (50 minutes), nutrition education lesson (20 minutes), and reflection period to talk about their experience in cooking lessons (25 minutes). On any day during the week, the students will make a dish using groceries they received (1 hour).
Study NCT05951361 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 980nm Diode Laser
Description: 300 mW, 4 J/cm2, 2mm non-contact mode up to 10 sessions
Study NCT05951361 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.1% topical triamcinolone Acetonide preparation Kenacourt-A Orabase
Description: three times daily for 4 weeks
Study NCT05515484 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: prone position with airbags
Description: prone position with airbags
Study NCT05515484 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: prone position without airbags
Description: prone position without airbags
Study NCT06501599 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Medical software (AI-based system)
Description: Retrospective analysis of chest CT images with medical software (AI-based system)
Study NCT05890014 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Flavonoid-rich diet
Description: Inclusion of foods rich in flavonoids.
Study NCT04200183 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: iACTwithPain (ACT+compassion)
Description: This intervention will deliver a eHealth ACT and compassion-based therapy (iACTwithPain) designed for chronic pain
Study NCT04200183 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACT-only intervention
Description: This intervention will deliver the iACTwithPain intervention but without the delivery of explicit compassion.
Study NCT05924841 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BL-B01D1
Description: Administration by intravenous infusion
Study NCT05924841 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SI-B003
Description: Administration by intravenous infusion
Study NCT05718440 — intervention group
Intervention type: OTHER
Intervention: Individualisation of uronephrological complications risk factors
Description: description of pelvic disorders in terms of clinical presentation, electrophysiology/urodynamics/anorectal manometry patterns, urethrocystography/urinary ultrasound/defecography results and urinary complications (infections, vesicoureteral reflux), depending on the dysraphim's type and level of injury and to correlate these parameters to the uronephrological risk factors and complications recorded.
Study NCT05013580 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Guided bone regeneration (GBR)
Description: Bone grafts will be placed in the patient's jawbone, along with a membrane to cover the bone grafts. A horizontal incision over the edentulous ridge crest will be made along with vertical incisions if indicated. Buccal and lingual full thickness mucoperiosteal flaps will be reflected to expose the alveolar bone. Intra-marrow penetration (decortication of the alveolar bone to increase vascular supply to the bone grafts) at the surgical site alveolar bone will be made with a high-speed hand piece and diamond bur. Bone allograft material will be placed to fill the alveolar bone defect. The bone graft will then be covered with a membrane and secured with sutures.
Study NCT05013580 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Guided bone regeneration (GBR)
Description: Bone grafts will be placed in the patient's jawbone, along with a membrane to cover the bone grafts. A horizontal incision over the edentulous ridge crest will be made along with vertical incisions if indicated. Buccal and lingual full thickness mucoperiosteal flaps will be reflected to expose the alveolar bone. Intra-marrow penetration (decortication of the alveolar bone to increase vascular supply to the bone grafts) at the surgical site alveolar bone will be made with a high-speed hand piece and diamond bur. Bone allograft material will be placed to fill the alveolar bone defect. The bone graft will then be covered with a membrane and secured with sutures.
Study NCT06231134 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional surgery
Description: an implant will be exposed using the conventional surgical exposure techniques with a tissue punch, the cover screw will be removed, and the healing abutment placed
Study NCT06231134 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Diode laser 940 nm
Description: implant will be uncovered using a diode laser (940nm) in contact type with a continuous mode at a power of 1.5 watts, the laser tip will be used in a circular motion to create a small opening which will be increased till large enough to expose and remove the cover screw and place the healing abutments.
Study NCT06231134 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrosurgical
Description: the monopolar electrosurgical device will be used in the same way as the laser tip with additional care avoiding contacting the implants during exposure.
Study NCT05612217 — intervention group
Intervention type: OTHER
Intervention: to estimate Sensitivity and Specificity AIVARIX app in detecting C1 and C2 classes of CVD
Description: to estimate Sensitivity and Specificity of the AI-based AIVARIX app in detecting C1 and C2 classes of CVD in patients who are seeking for professional advice from a phlebologist regarding symptoms and signs suggestive to CVD.
Study NCT04854070 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IVUS
Description: IVUS-guided approach in patients with complex coronary lesions undergoing PCI
Study NCT04854070 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Angio
Description: Angio-guided approach in patients with complex coronary lesions undergoing PCI
Study NCT05459337 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MuST AKT
Description: A behavioural intervention designed to help participants identify and communicate with their social network about living kidney donation.
Study NCT04283435 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sildenafil Citrate
Description: Sildenafil Citrate 50 mg tablets taken from the first day of the cycle till the day we start progesterone (we stop 3 days before embryo transfer)
Study NCT04283435 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablet (multivitamins),Pregnacare vitamins (Vitabiotics,UK)
Study NCT04283435 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Estradiol Valerate
Description: Estradiol valerate tablets 2mg every 8 hours daily starting from the fist day of the cycle till 12th day of the menstrual cycle.
Study NCT04283435 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Estradiol Valerate
Description: Estradiol valerate tablets 2mg every 8 hours daily starting from the fist day of the cycle till 12th day of the menstrual cycle.
Study NCT05171270 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: PsAID questionnaire
Study NCT05385341 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation (Tele RCV)
Description: 20 home-based sessions monitored by the REMOTE-ACS device and containing 2 hours/day 5 days/7 of exercise training associated with educative sessions.
Study NCT05385341 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation (RCV)
Description: 20 sessions of cardiac rehabilitation will be realized in a rehabilitation center containing exercise training during 2 hours/day 5 days/7 and educative program.
Study NCT06136260 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CommunityRx-Bereavement
Description: The medical examiner or coroner will refer parents to an organization called Missing Pieces. Missing Pieces does not deliver healthcare services to grieving families; rather, Missing Pieces helps families find grief services in their community.~For CRx-B, a Grief Navigator from Missing Pieces will text and/or call the parent after receiving the referral; share information about grief and support resources; learn what resources the parent needs for themselves and their family; send the parent a personalized list of grief and social support community resources called a HealtheRx via text, email, or mail; and plan future text message communications with bidirectional functionality and, if requested, subsequent calls or texts from the Grief Navigator to occur at least 3, 6, and 12 months after the child's death.
Study NCT06136260 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: General Bereavement Support Information
Description: The medical examiner or coroner will refer parents to an organization called Missing Pieces. Missing Pieces does not deliver healthcare services to grieving families; rather, Missing Pieces helps families find grief services in their community.~For GBSI, Missing Pieces sends parents a unidirectional text message providing a link to a webpage with a general list of grief resources (e.g., support groups) and information about grief and bereavement within two weeks of the child's death and again 3, 6, and 12 months after the child's death.
Study NCT05177068 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fruquintinib + sintilimab + SOX
Description: fruquintinib: 4mg/d, qd po, d1-14, q3w; sintilimab: 200 mg/d, IV d1, q3w; S-1: BSA\<1.25 m2, 40mg twice/day; BSA1.25-1.5m2, 50mg twice/day; BSA≥1.5 m2, 60mg twice/day, po, d1-14, q3w; oxaliplatin: 130mg/m2, ivgtt 2-6h, d1, q3w
Study NCT05627947 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mitomycin c
Description: Comparing the effect of Mitomycin C versus Cyclosporine after primary pterygium surgery
Study NCT05475899 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Instrument assisted soft tissue mobilization
Description: Application of IASTM on the plantar fascia with 10-15 strokes followed by stretching
Study NCT05475899 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Instrument assisted soft tissue mobilization
Description: Application of IASTM on the plantar fascia with 10-15 strokes followed by stretching
Study NCT05088681 — intervention group
Intervention type: OTHER
Intervention: Rehabilitation program
Description: The exercise intervention will consist of an individualized prescription of resistance training, balance training and cardiovascular exercises delivered for 20 session, one-hour, two/three times per week.
Study NCT05314777 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Low dose ESWT application
Description: Patients trained for low dose ESWT application.
Study NCT05314777 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High dose ESWT application
Description: Patients trained for high dose ESWT application.
Study NCT05314777 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sham ESWT
Description: Patients trained for sham ESWT.
Study NCT05314777 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Exercise Training
Description: Patients trained for exercise training.
Study NCT05314777 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Exercise Training
Description: Patients trained for exercise training.
Study NCT06639997 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD5148
Description: Participants will receive AZD5148 as IM injection or IV bolus
Study NCT05195216 — intervention group
Intervention type: BEHAVIORAL
Intervention: Survey Form, The Hospital Anxiety and Depression Scale, The Fear of COVID-19 Scale,World Health Organization Quality of Life Scale- Bref Form
Description: Online questionnaires were administered to individuals.
Study NCT05038449 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Colchicine Tablets
Description: Colchicine Tablets (Each tablet contains colchicine 0.5mg)
Study NCT05038449 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Standard therapy
Description: Standard therapy for COVID-19 according to the Novel Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial 8th Edition)
Study NCT05038449 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Standard therapy
Description: Standard therapy for COVID-19 according to the Novel Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial 8th Edition)
Study NCT06076187 — intervention group
Intervention type: OTHER
Intervention: Dual isotope method
Description: Dual isotope method
Study NCT06121440 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Listening to audiobook
Description: Audiobook by children will be chosen by child psychologists. The books will be played to children via tablet computers. The researcher has a fairy tale therapy certificate. The audiobook listening will start 5 minutes before the tracheostomy care process and will continue throughout the tracheostomy care process. Audiobook will be listen to children only one day.
Study NCT06121440 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Playing musical-moving toy
Description: Musical-moving toy by children will be chosen by child psychologists. The toy will be played to children by the researcher. Playing musical-moving toy will start 5 minutes before the tracheostomy care process and will continue throughout the tracheostomy care process. The toy will be played to children only one day.
Study NCT05413226 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Celastrol
Description: Four increasing doses of Celastrol to each of five men.
Study NCT05395156 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Description: Control group will receive TEAS on sham acupoint daily from 3 days before menstruation to the 4th day of menstruation for 3 consequent menstrual cycles Study group will receive TEAS on neurogenic acupoints daily from 3 days before menstruation to the 4th day of menstruation for 3 consequent menstrual cycles
Study NCT06180161 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: multidomain intervention
Description: Integrating exercise cognitive training with nutrition, chronic disease management, oral health, fall prevention, traffic safety, psychosocial well-being, and sleep to enhance the effectiveness of improving cognitive function in the elderly community.
Study NCT05598749 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Arabic gum, sucrose and silicon dioxide mix